Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing etoricoxib and pharmaceutically acceptable salt thereof

A kind of etoricoxib, pharmaceutical technology, applied in the field of salt preparation, can solve the problem of increasing risk

Inactive Publication Date: 2015-07-08
JINAN SANYUAN CHEM CO LTD
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Processes involving these hazardous chemicals increase risks in process control and result in possible risks to operators and the environment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing etoricoxib and pharmaceutically acceptable salt thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Preparation of 2-hydroxy-3-p-methylthiophenyl-5-chloropyridine (compound 2)

[0024] Add 2-chloromalondialdehyde (16.0g, about 0.15mol) and p-methylthiophenylacetamide (18.1g, about 0.1mol) to ethanol (150ml), stir at room temperature for 10min, slowly add 3ml of pyridine dropwise, gradually The temperature was raised to reflux, and the reaction was stirred for 4 hours. After the reaction was completed, the solvent was evaporated, and the product was dissolved in ethyl acetate, washed with a saturated solution of sodium bicarbonate (3×50ml) and brine, dried with anhydrous sodium sulfate, and concentrated to obtain a residue Crystallization in hexane / ether gave 24.3 g of 2-hydroxy-3-p-methylthiophenyl-5-chloropyridine.

Embodiment 2a

[0026] 2-Hydroxy-3-p-methylthiophenyl-5-chloropyridine (15.1 g, about 0.06 mol) was mixed with POCl in a sealed jar 3 (150ml) were heated together at 140°C for 15 hours, after cooling to room temperature, the excess POCl was distilled off under reduced pressure 3 The residue was diluted with ethyl acetate and water, then neutralized to a pH of about 7 with saturated sodium bicarbonate solution. The organic phase was taken out, washed with brine and concentrated, and the residual solid was recrystallized in hexane / ether to obtain 13.8 g of 2,5-dichloro-3-p-methylthiophenylpyridine.

[0027]

Embodiment 2b

[0029] The POCl in embodiment 2a 3 Replaced by POBr 3 , and the rest of the reaction conditions remained unchanged to obtain 16.5 g of 2-bromo-3-p-methylthiophenyl-5-chloropyridine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing etoricoxib. The method comprises the following steps: (a) reacting 2-chloromalonaldehyde (compound 1) with methylthio phenyl acetamide (compound 2) toprepare 2-hydroxy-3-methylthio phenyl-5-chloropyridine compound 3); (b) reacting the compound 3 with phosphorus oxytrihalide to prepare 2-halogeno-3-methylthio phenyl-5-chloropyridine (compound 4); (c) reacting compound 4 with hydrogen peroxide to prepare 2-halogeno-3-p-methyl sulfonyl phenyl-5-chloropyridine (compound 5); and (d) coupling the compound 5 with 2-methyl-pyridine-5-boric acid under the catalysis of palladium to obtain etoricoxib. The preparation method has the advantages of high purity, high yield, low cost and easy operation.

Description

technical field [0001] The invention relates to a preparation method of an anti-inflammatory drug etoricoxib or a pharmaceutically acceptable salt thereof. Background technique [0002] Etoricoxib, chemically known as 5-chloro-2-(2-methyl-5-pyridyl)-3-p-methylsulfonylphenylpyridine, is a potent and selective cyclooxygenase-2 Inhibitor, which has anti-inflammatory, antipyretic and analgesic properties. Etoricoxib has been approved by regulatory authorities for clinical use as a non-steroidal anti-inflammatory drug. The drug is marketed as film-coated tablets under the trade name Arcoxia and has the following structural formula: [0003] [0004] This compound was disclosed in EP0912518B1 for the first time, and its preparation method is synthesized by palladium-catalyzed coupling of aryl / pyridyl halides with aryl / pyridyl boronic acid or stannane. The above preparation method is difficult to produce on a large scale and the material cost is expensive. [0005] EP0975596B...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/61
CPCC07D213/61
Inventor 宫庆创李国丽司志现
Owner JINAN SANYUAN CHEM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com